Ultimately, overexpression of E2F3, which is an oncogene in tumorigenesis, is associated with a poor prognosis in a variety of human malignancies, such as hepatocellular carcinoma [31]. This evidence concerns the gene E2F3 and hepatocellular carcinoma.